Uncommon, a UK-based start-up, secures $30m in Series A funding to expand its RNA lab-cultivated bacon and pork belly operation. The capital will strengthen regulatory compliance, drive down costs, and increase production capabilities at its pilot factory for a 5% global market share by 2035. With over $35m in total funding, Uncommon stands out from the cell-based meat field with the RNA lab process, backed by Balderton and Lowercarbon investors.
Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?